Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cai Read

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Biochemical Pharmacology|August 1, 2016
Cardiac action of the first G protein biased small molecule apelin agonistCai Read, Christopher M Fitzpatrick, Peiran Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 25, 2021
G protein signaling-biased mu opioid receptor agonists that produce sustained G protein activation are noncompetitive agonistsEdward L Stahl, Cullen L Schmid, Agnes Acevedo-Canabal, et al.
Journal of the American Heart Association|October 16, 2016
Chemerin Elicits Potent Constrictor Actions via Chemokine-Like Receptor 1 (CMKLR1), not G-Protein-Coupled Receptor 1 (GPR1), in Human and Rat VasculatureAmanda J Kennedy, Peiran Yang, Cai Read, et al.
Frontiers in Pharmacology|March 15, 2021
The G Protein Biased Small Molecule Apelin Agonist CMF-019 is Disease Modifying in Endothelial Cell Apoptosis <i>In Vitro</i> and Induces Vasodilatation Without Desensitisation <i>In Vivo</i>Cai Read, Duuamene Nyimanu, Peiran Yang, et al.
Pharmacological Reviews|September 8, 2019
International Union of Basic and Clinical Pharmacology. CVII. Structure and Pharmacology of the Apelin Receptor with a Recommendation that Elabela/Toddler Is a Second Endogenous Peptide LigandCai Read, Duuamene Nyimanu, Thomas L Williams, et al.
Basic & Clinical Pharmacology & Toxicology|March 23, 2019
Apelin peptides linked to anti-serum albumin domain antibodies retain affinity in vitro and are efficacious receptor agonists in vivoCai Read, Peiran Yang, Rhoda E Kuc, et al.
British Journal of Pharmacology|February 3, 2019
A novel cyclic biased agonist of the apelin receptor, MM07, is disease modifying in the rat monocrotaline model of pulmonary arterial hypertensionPeiran Yang, Cai Read, Rhoda E Kuc, et al.
Circulation|February 1, 2017
Elabela/Toddler Is an Endogenous Agonist of the Apelin APJ Receptor in the Adult Cardiovascular System, and Exogenous Administration of the Peptide Compensates for the Downregulation of Its Expression in Pulmonary Arterial HypertensionPeiran Yang, Cai Read, Rhoda E Kuc, et al.
Thorax|December 17, 2018
Growth/differentiation factor 15 causes TGFβ-activated kinase 1-dependent muscle atrophy in pulmonary arterial hypertensionBenjamin E Garfield, Alexi Crosby, Dongmin Shao, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Biochemical Pharmacology|August 1, 2016
Cardiac action of the first G protein biased small molecule apelin agonistCai Read, Christopher M Fitzpatrick, Peiran Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 25, 2021
G protein signaling-biased mu opioid receptor agonists that produce sustained G protein activation are noncompetitive agonistsEdward L Stahl, Cullen L Schmid, Agnes Acevedo-Canabal, et al.
Journal of the American Heart Association|October 16, 2016
Chemerin Elicits Potent Constrictor Actions via Chemokine-Like Receptor 1 (CMKLR1), not G-Protein-Coupled Receptor 1 (GPR1), in Human and Rat VasculatureAmanda J Kennedy, Peiran Yang, Cai Read, et al.
Frontiers in Pharmacology|March 15, 2021
The G Protein Biased Small Molecule Apelin Agonist CMF-019 is Disease Modifying in Endothelial Cell Apoptosis <i>In Vitro</i> and Induces Vasodilatation Without Desensitisation <i>In Vivo</i>Cai Read, Duuamene Nyimanu, Peiran Yang, et al.
Pharmacological Reviews|September 8, 2019
International Union of Basic and Clinical Pharmacology. CVII. Structure and Pharmacology of the Apelin Receptor with a Recommendation that Elabela/Toddler Is a Second Endogenous Peptide LigandCai Read, Duuamene Nyimanu, Thomas L Williams, et al.
Basic & Clinical Pharmacology & Toxicology|March 23, 2019
Apelin peptides linked to anti-serum albumin domain antibodies retain affinity in vitro and are efficacious receptor agonists in vivoCai Read, Peiran Yang, Rhoda E Kuc, et al.
British Journal of Pharmacology|February 3, 2019
A novel cyclic biased agonist of the apelin receptor, MM07, is disease modifying in the rat monocrotaline model of pulmonary arterial hypertensionPeiran Yang, Cai Read, Rhoda E Kuc, et al.
Circulation|February 1, 2017
Elabela/Toddler Is an Endogenous Agonist of the Apelin APJ Receptor in the Adult Cardiovascular System, and Exogenous Administration of the Peptide Compensates for the Downregulation of Its Expression in Pulmonary Arterial HypertensionPeiran Yang, Cai Read, Rhoda E Kuc, et al.
Thorax|December 17, 2018
Growth/differentiation factor 15 causes TGFβ-activated kinase 1-dependent muscle atrophy in pulmonary arterial hypertensionBenjamin E Garfield, Alexi Crosby, Dongmin Shao, et al.
Pageof 1